<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40-vaccines-08-00115">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Macchi</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Rojas</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Verna</surname>
    <given-names>A.E.</given-names>
   </name>
   <name>
    <surname>Sevilla</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Franceschi</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Tebaldi</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Cavirani</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Martin</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Donofrio</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>Bovine herpesvirus-4-based vector delivering peste des petits ruminants virus hemagglutinin ORF induces both neutralizing antibodies and cytotoxic T cell responses</article-title>
  <source>Front. Immunol.</source>
  <year>2018</year>
  <volume>9</volume>
  <fpage>421</fpage>
  <pub-id pub-id-type="doi">10.3389/fimmu.2018.00421</pub-id>
  <pub-id pub-id-type="pmid">29556236</pub-id>
 </element-citation>
</ref>
